These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17943539)

  • 1. Long-term effects of progestins on bone quality and fractures.
    Thijssen JH
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():45-52. PubMed ID: 17943539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
    Studd J
    Climacteric; 2009 Jun; 12(3):206-9. PubMed ID: 19437196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
    Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and osteoporosis: a clinical review.
    Gonyeau MJ
    Pharmacotherapy; 2005 Feb; 25(2):228-43. PubMed ID: 15767237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium and bone metabolism across women's life stages. The effects of oral contraceptives/low dose estrogen-progestin on bone metabolism, bone mass and geometry in adolescent and young adult women.].
    Okano H
    Clin Calcium; 2017; 27(5):661-671. PubMed ID: 28439054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview on the effects of progestins on bone.
    Thijssen JH
    Maturitas; 2003 Dec; 46 Suppl 1():S77-87. PubMed ID: 14670649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of effect of progestogen on bone.
    Lindsay R
    J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of thiazolidinediones on BMD and osteoporosis.
    McDonough AK; Rosenthal RS; Cao X; Saag KG
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins and bone.
    Thijssen JH
    Zentralbl Gynakol; 1997; 119 Suppl 2():70-4. PubMed ID: 9361396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of osteoporosis with Teriparatide rhPTH(1-34).
    San Martin J
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):406. PubMed ID: 15758281
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of hormonal contraceptives on bone turnover markers and bone health.
    Herrmann M; Seibel MJ
    Clin Endocrinol (Oxf); 2010 May; 72(5):571-83. PubMed ID: 19740118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.